Home › Funds › Epoch Investment Partners, Inc. › UTHR

Epoch Investment Partners, Inc. position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

Epoch Investment Partners, Inc. reported holding 204,552 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$110.8M, representing 0.66% of its reported portfolio and ranking #45 among its reported holdings. Epoch Investment Partners, Inc. has disclosed UTHR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)204.55K sh
Reported value held$110.84M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Epoch Investment Partners, Inc.'s UTHR position evolved

Epoch Investment Partners, Inc. first disclosed a stake in UTHR in Q3 2023 at 137,779 shares (US$31.1M). The position peaked in Q3 2026 at 204,552 shares, worth US$110.8M. Across 13 filings, Epoch Investment Partners, Inc. increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 204,552 shares valued at US$110.8M — an increase of 53,908 shares quarter over quarter.. Notable position changes include a 55% increase in Q4 2023 (shares rose 4% over the following quarter), a 31% trim in Q4 2025 (shares rose 22% over the following quarter), a 36% increase in Q3 2026 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 137.78K $31.12M New
Q4 2023 213.18K $46.88M Add
Q1 2024 213.50K $49.04M Hold
Q2 2024 226.66K $72.20M Add
Q3 2024 238.79K $85.57M Add
Q4 2024 226.21K $79.82M Reduce
Q1 2025 285.87K $88.13M Add
Q2 2025 291.49K $83.76M Add
Q3 2025 205.78K $86.27M Reduce
Q4 2025 142.29K $69.33M Reduce
Q1 2026 120.68K $71.56M Reduce
Q2 2026 150.64K $81.62M Add
Q3 2026 204.55K $110.84M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 39 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has Epoch Investment Partners, Inc. held UTHR?

Epoch Investment Partners, Inc. has disclosed UTHR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Epoch Investment Partners, Inc.'s current position in UTHR?

As of Q3 2026, Epoch Investment Partners, Inc. holds 204.55K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $110.84M, representing 0.66% of its reported portfolio and ranking #45.

Has Epoch Investment Partners, Inc. been buying or selling UTHR?

In the latest 13F filing (Q3 2026), Epoch Investment Partners, Inc. increased its position in UTHR. The position peaked in Q3 2026 at 204.55K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.